fluoxetine has been researched along with Mucopolysaccharidosis III in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Mucopolysaccharidosis III: Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capuozzo, A | 1 |
| Montefusco, S | 1 |
| Cacace, V | 1 |
| Sofia, M | 1 |
| Esposito, A | 1 |
| Napolitano, G | 1 |
| Nusco, E | 1 |
| Polishchuk, E | 1 |
| Pizzo, MT | 1 |
| De Risi, M | 1 |
| De Leonibus, E | 1 |
| Sorrentino, NC | 1 |
| Medina, DL | 1 |
1 other study available for fluoxetine and Mucopolysaccharidosis III
| Article | Year |
|---|---|
Fluoxetine ameliorates mucopolysaccharidosis type IIIA.
Topics: Animals; Disease Models, Animal; Fibroblasts; Fluoxetine; Heparitin Sulfate; Hydrolases; Mice; Mucop | 2022 |